Shares of this micro-cap company hit upper circuit as it announces their business expansion!
Shares of this micro-cap company hit upper circuit as it announces their business expansion!

Shares of this micro-cap company hit upper circuit as it announces their business expansion!

On Monday, shares of the company surged by 19.97 per cent and reached its upper circuit of Rs 27.64. Moreover, the stock had a spurt in volume by more than 12.64 times.

Siddharth Mane Article rating: 4.2

The company has given great returns of 81 per cent over the past 3 years and have given excellent returns of 122 per cent over the past 5 years.

Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it?
Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it?

Advent International buys more than 50 per cent stake for Rs 6300 crore in this pharma company. Do you own it?

Advent is expected to buy 51 per cent of the promoter’s stake in the company and launch an open offer for an additional 26 per cent

Bhavya Rathod Article rating: 4.3

The company released a press release on Monday, stating Advent International has entered into definitive agreement to acquire significant stake in the company and intends to explore the merger of  its portfolio company

Shares below Rs 100: Only buyers were seen in these stocks on December 21!
Shares below Rs 100: Only buyers were seen in these stocks on December 21!

Shares below Rs 100: Only buyers were seen in these stocks on December 21!

BSE Healthcare surprised investors with gains of about 2 per cent in such a lackluster market, led by IOL Chemicals and Pharmaceuticals.

Mandar Wagh Article rating: 4.1

BSE Healthcare surprised investors with gains of about 2 per cent in such a lackluster market, led by IOL Chemicals and Pharmaceuticals.  

Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it?
Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it?

Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it?

This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness.

Kiran Shroff Article rating: 4.3

This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness.

This pharma company stock went 8 per cent high, do you own it?
This pharma company stock went 8 per cent high, do you own it?

This pharma company stock went 8 per cent high, do you own it?

With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

Kiran Shroff Article rating: 5.0

This pharma company stock went 8 per cent high, do you own it?                                                                                                                                                                                                       With its shares up 8 per cent, the Indian multinational pharmaceutical company posted a net profit of Rs 130 crore in the second quarter, while its turnover increased to Rs 4,145 crore.

Overnight Digest: Stocks to keep an eye on August 30
Overnight Digest: Stocks to keep an eye on August 30

Overnight Digest: Stocks to keep an eye on August 30

Keep an eye on these stocks in tomorrow's trading session.

Sayali Kotwal Article rating: 3.9

 At the time of Monday’s closing bell, the markets tanked, owing to the heavy sell-off prompted by Fed Chairman’s comments on inflation on Friday.  

RSS
12

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR